• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Brd4-p300 抑制作用下调 Nox4 并加速老年小鼠肺纤维化的解决。

Brd4-p300 inhibition downregulates Nox4 and accelerates lung fibrosis resolution in aged mice.

出版信息

JCI Insight. 2020 Jul 23;5(14):137127. doi: 10.1172/jci.insight.137127.

DOI:10.1172/jci.insight.137127
PMID:32544088
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7453889/
Abstract

Tissue regeneration capacity declines with aging in association with heightened oxidative stress. Expression of the oxidant-generating enzyme, NADPH oxidase 4 (Nox4), is elevated in aged mice with diminished capacity for fibrosis resolution. Bromodomain-containing protein 4 (Brd4) is a member of the bromodomain and extraterminal (BET) family of proteins that function as epigenetic "readers" of acetylated lysine groups on histones. In this study, we explored the role of Brd4 and its interaction with the p300 acetyltransferase in the regulation of Nox4 and the in vivo efficacy of a BET inhibitor to reverse established age-associated lung fibrosis. BET inhibition interferes with the association of Brd4, p300, and acetylated histone H4K16 with the Nox4 promoter in lung fibroblasts stimulated with the profibrotic cytokine, TGF-β1. A number of BET inhibitors, including I-BET-762, JQ1, and OTX015, downregulate Nox4 gene expression and activity. Aged mice with established and persistent lung fibrosis recover capacity for fibrosis resolution with OTX015 treatment. This study implicates epigenetic regulation of Nox4 by Brd4 and p300 and supports BET/Brd4 inhibition as an effective strategy for the treatment of age-related fibrotic lung disease.

摘要

随着年龄的增长,组织再生能力会下降,同时氧化应激水平也会升高。在纤维化消退能力减弱的老年小鼠中,氧化应激生成酶 NADPH 氧化酶 4(Nox4)的表达水平升高。溴结构域蛋白 4(Brd4)是溴域和末端(BET)蛋白家族的成员,作为组蛋白上乙酰化赖氨酸组的表观遗传“读取器”发挥作用。在这项研究中,我们探讨了 Brd4 及其与 p300 乙酰转移酶的相互作用在 Nox4 调节中的作用,以及 BET 抑制剂逆转已建立的与年龄相关的肺纤维化的体内疗效。BET 抑制干扰了在 TGF-β1 刺激的肺成纤维细胞中,Brd4、p300 和乙酰化组蛋白 H4K16 与 Nox4 启动子的结合。许多 BET 抑制剂,包括 I-BET-762、JQ1 和 OTX015,下调 Nox4 基因表达和活性。用 OTX015 治疗已建立和持续存在的肺纤维化的老年小鼠恢复了纤维化消退的能力。这项研究表明,Brd4 和 p300 通过表观遗传调控 Nox4,并支持 BET/Brd4 抑制作为治疗与年龄相关的纤维性肺疾病的有效策略。

相似文献

1
Brd4-p300 inhibition downregulates Nox4 and accelerates lung fibrosis resolution in aged mice.Brd4-p300 抑制作用下调 Nox4 并加速老年小鼠肺纤维化的解决。
JCI Insight. 2020 Jul 23;5(14):137127. doi: 10.1172/jci.insight.137127.
2
Brd4 inhibition attenuates unilateral ureteral obstruction-induced fibrosis by blocking TGF-β-mediated Nox4 expression.Brd4抑制通过阻断TGF-β介导的Nox4表达减轻单侧输尿管梗阻诱导的纤维化。
Redox Biol. 2017 Apr;11:390-402. doi: 10.1016/j.redox.2016.12.031. Epub 2016 Dec 30.
3
Bromodomain and Extraterminal (BET) Protein Inhibition Restores Redox Balance and Inhibits Myofibroblast Activation.Bromodomain 和末端结构域(BET)蛋白抑制作用可恢复氧化还原平衡并抑制肌成纤维细胞激活。
Biomed Res Int. 2019 Apr 18;2019:1484736. doi: 10.1155/2019/1484736. eCollection 2019.
4
Targeting BRD4 proteins suppresses the growth of NSCLC through downregulation of eIF4E expression.靶向 BRD4 蛋白通过下调 eIF4E 表达抑制 NSCLC 的生长。
Cancer Biol Ther. 2018 May 4;19(5):407-415. doi: 10.1080/15384047.2018.1423923. Epub 2018 Feb 6.
5
Pharmacological targeting of BET proteins attenuates radiation-induced lung fibrosis.靶向 BET 蛋白的药理学治疗可减轻放射性肺纤维化。
Sci Rep. 2018 Jan 17;8(1):998. doi: 10.1038/s41598-018-19343-9.
6
Nanog requires BRD4 to maintain murine embryonic stem cell pluripotency and is suppressed by bromodomain inhibitor JQ1 together with Lefty1.Nanog需要BRD4来维持小鼠胚胎干细胞的多能性,并与Lefty1一起被溴结构域抑制剂JQ1抑制。
Stem Cells Dev. 2015 Apr 1;24(7):879-91. doi: 10.1089/scd.2014.0302. Epub 2014 Dec 17.
7
Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1.溴结构域蛋白 4(BRD4)与组蛋白 H4 尾部和小分子抑制剂 JQ1 的相互作用亲和图。
J Biol Chem. 2014 Mar 28;289(13):9304-19. doi: 10.1074/jbc.M113.523019. Epub 2014 Feb 4.
8
BET Bromodomain Blockade Mitigates Intimal Hyperplasia in Rat Carotid Arteries.BET 溴结构域抑制剂可减轻大鼠颈动脉内膜增生。
EBioMedicine. 2015 Sep 28;2(11):1650-61. doi: 10.1016/j.ebiom.2015.09.045. eCollection 2015 Nov.
9
BET bromodomain proteins mediate downstream signaling events following growth factor stimulation in human lung fibroblasts and are involved in bleomycin-induced pulmonary fibrosis.BET 溴结构域蛋白在人肺成纤维细胞受到生长因子刺激后介导下游信号事件,并参与博来霉素诱导的肺纤维化。
Mol Pharmacol. 2013 Jan;83(1):283-93. doi: 10.1124/mol.112.081661. Epub 2012 Oct 31.
10
Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis.评估特发性肺纤维化肺成纤维细胞中的 Brd4 抑制作用及肺纤维化的体内模型。
Am J Pathol. 2013 Aug;183(2):470-9. doi: 10.1016/j.ajpath.2013.04.020. Epub 2013 Jun 10.

引用本文的文献

1
BRD4 Mediates Transforming Growth Factor-β-Induced Smooth Muscle Cell Differentiation from Mesenchymal Progenitor Cells.BRD4介导转化生长因子-β诱导间充质祖细胞向平滑肌细胞分化。
Int J Mol Sci. 2025 Aug 21;26(16):8074. doi: 10.3390/ijms26168074.
2
Epithelial Cell Dysfunction in Pulmonary Fibrosis: Mechanisms, Interactions, and Emerging Therapeutic Targets.肺纤维化中的上皮细胞功能障碍:机制、相互作用及新兴治疗靶点
Pharmaceuticals (Basel). 2025 May 28;18(6):812. doi: 10.3390/ph18060812.
3
The ESCRT protein CHMP5 promotes T cell leukemia by enabling BRD4-p300-dependent transcription.内体分选转运复合体(ESCRT)蛋白CHMP5通过促进依赖于BRD4-p300的转录来推动T细胞白血病。
Nat Commun. 2025 May 3;16(1):4133. doi: 10.1038/s41467-025-59504-9.
4
BRD4 Mediates Cadmium-Induced Oxidative Stress and Kidney Injury in Mice via Disruption of Redox Homeostasis.BRD4通过破坏氧化还原稳态介导镉诱导的小鼠氧化应激和肾损伤。
Toxics. 2025 Mar 29;13(4):258. doi: 10.3390/toxics13040258.
5
A Micro-Computed Tomography-Based Simplified Approach to Measure Body Composition, Osteoporosis, and Lung Fibrosis in Mice.一种基于微型计算机断层扫描的简化方法,用于测量小鼠的身体成分、骨质疏松症和肺纤维化。
Bio Protoc. 2025 Feb 20;15(4):e5207. doi: 10.21769/BioProtoc.5207.
6
The Sound of Silence: Suppressing CBX5 Decreases Fibrosis by Inhibiting Fibroblasts.寂静之声:抑制CBX5通过抑制成纤维细胞减少纤维化。
Am J Respir Cell Mol Biol. 2025 Jun;72(6):605-606. doi: 10.1165/rcmb.2024-0618ED.
7
BRD4: an effective target for organ fibrosis.BRD4:器官纤维化的有效靶点。
Biomark Res. 2024 Aug 30;12(1):92. doi: 10.1186/s40364-024-00641-6.
8
Inhibition of CK2 Diminishes Fibrotic Scar Formation and Improves Outcomes After Ischemic Stroke via Reducing BRD4 Phosphorylation.抑制 CK2 可减少缺血性脑卒中后的纤维瘢痕形成,并通过降低 BRD4 磷酸化改善预后。
Neurochem Res. 2024 May;49(5):1254-1267. doi: 10.1007/s11064-024-04112-0. Epub 2024 Feb 21.
9
The ESCRT protein CHMP5 promotes T cell leukemia by controlling BRD4-p300-dependent transcription.内体分选转运复合体(ESCRT)蛋白CHMP5通过控制BRD4-p300依赖的转录促进T细胞白血病。
bioRxiv. 2024 Jan 31:2024.01.29.577409. doi: 10.1101/2024.01.29.577409.
10
BET Protein Inhibitor JQ1 Ameliorates Experimental Peritoneal Damage by Inhibition of Inflammation and Oxidative Stress.BET蛋白抑制剂JQ1通过抑制炎症和氧化应激改善实验性腹膜损伤。
Antioxidants (Basel). 2023 Nov 29;12(12):2055. doi: 10.3390/antiox12122055.

本文引用的文献

1
HDAC inhibitors as antifibrotic drugs in cardiac and pulmonary fibrosis.组蛋白去乙酰化酶抑制剂作为心脏和肺纤维化中的抗纤维化药物
Ther Adv Chronic Dis. 2019 Jul 18;10:2040622319862697. doi: 10.1177/2040622319862697. eCollection 2019.
2
Pharmacological characterization of the seven human NOX isoforms and their inhibitors.七种人类 NOX 同工型及其抑制剂的药理学特性。
Redox Biol. 2019 Sep;26:101272. doi: 10.1016/j.redox.2019.101272. Epub 2019 Jul 11.
3
Bromodomain and Extraterminal (BET) Protein Inhibition Restores Redox Balance and Inhibits Myofibroblast Activation.Bromodomain 和末端结构域(BET)蛋白抑制作用可恢复氧化还原平衡并抑制肌成纤维细胞激活。
Biomed Res Int. 2019 Apr 18;2019:1484736. doi: 10.1155/2019/1484736. eCollection 2019.
4
The BET Bromodomain Inhibitor I-BET-151 Induces Structural and Functional Alterations of the Heart Mitochondria in Healthy Male Mice and Rats.BET 溴结构域抑制剂 I-BET-151 诱导健康雄性小鼠和大鼠心脏线粒体的结构和功能改变。
Int J Mol Sci. 2019 Mar 27;20(7):1527. doi: 10.3390/ijms20071527.
5
Bromodomain and extra-terminal motif inhibitors: a review of preclinical and clinical advances in cancer therapy.溴结构域和额外末端基序抑制剂:癌症治疗的临床前和临床进展综述
Future Sci OA. 2019 Jan 29;5(3):FSO372. doi: 10.4155/fsoa-2018-0115. eCollection 2019 Mar.
6
BRD4 and Cancer: going beyond transcriptional regulation.BRD4 与癌症:超越转录调控。
Mol Cancer. 2018 Nov 22;17(1):164. doi: 10.1186/s12943-018-0915-9.
7
Brd4's Bromodomains Mediate Histone H3 Acetylation and Chromatin Remodeling in Pluripotent Cells through P300 and Brg1.Brd4 的溴结构域通过 P300 和 Brg1 介导多能细胞中的组蛋白 H3 乙酰化和染色质重塑。
Cell Rep. 2018 Nov 13;25(7):1756-1771. doi: 10.1016/j.celrep.2018.10.003.
8
Oxidative stress caused by activation of NADPH oxidase 4 promotes contrast-induced acute kidney injury.NADPH氧化酶4激活所引起的氧化应激促进造影剂诱导的急性肾损伤。
PLoS One. 2018 Jan 12;13(1):e0191034. doi: 10.1371/journal.pone.0191034. eCollection 2018.
9
Brd4 binds to active enhancers to control cell identity gene induction in adipogenesis and myogenesis.Brd4 结合到活性增强子上,以控制脂肪生成和肌生成过程中细胞身份基因的诱导。
Nat Commun. 2017 Dec 20;8(1):2217. doi: 10.1038/s41467-017-02403-5.
10
Heterogeneity of Fibroblasts and Myofibroblasts in Pulmonary Fibrosis.肺纤维化中成纤维细胞和平滑肌肌动蛋白阳性成纤维细胞的异质性
Curr Pathobiol Rep. 2017 Jun;5(2):101-110. doi: 10.1007/s40139-017-0134-x. Epub 2017 May 2.